Drug Use & Abuse
Student Name
COH318
Point/Counterpoint Outline
Date
TITLE
|
State the question from the list of approved topics, word for word.
|
Should Naloxone be allowed to be administered by anyone in order to save a life in case of a narcotic overdose emergency?
|
INTRODUCTORY PARAGRAPH
|
Introduce the topic and include the point and counterpoint without providing an opinion. |
Naloxone effectively reverses narcotic overdose, is legal to possess with a prescription, is fairly inexpensive, and has no psychotropic effects or potential for abuse. Those who support widespread distribution of naloxone and advocate for training lay people to use it say it will potentially save more human lives. Those against its widespread use fear possible accidental overdoses, masking the addiction problem, or potential increase in drug use. |
FIRST SECTION
|
Overall argument FOR (point)
|
Distribution programs that allow family members and friends to administer naloxone save lives and combats the rising number of narcotic overdose cases. |
|
#1 Argument FOR
|
Naloxone is easy to administer with proper education, awareness and training. Intranasal administration of naloxone has multiple benefits compared to intravenous routes, including no required medical intravenous venipuncture skills, and eliminates the risks of needle-stick injuries and blood-borne diseases.
|
|
#2 Argument FOR |
People without professional medical backgrounds have demonstrated competence using other methods to respond to an emergency. Anyone with initiative and ability to follow easy instructions can save the life of someone who overdoses on opioids.
|
|
#3 Argument FOR
|
Many professionals support more widespread use of intranasal naloxone by non-advanced life support providers. Removing the barrier that prevents EMTs from administering naloxone could help prevent thousands of drug overdose deaths annually. |
|
Concluding sentence |
Anyone with initiative and ability to follow easy instructions can save the life of someone who overdoses on opioids. |
SECOND SECTION
|
Transition (i.e., On the other hand) Overall argument AGAINST (counterpoint)
|
Whereas widespread distribution of naloxone may seem good on its face, it could lead to further complications, such as possible accidental overdoses, perpetuation of addiction or increase in drug use. |
|
#1 Argument AGAINST
|
Narcotics abusers may develop a false sense of security that having access to naloxone may make them safe from an overdose. Users may increase their drug dosages due to this bravado. Users may simply increase their overall intake to off-set any withdrawal effects.
|
|
#2 Argument AGAINST
|
A major benefit for receiving treatment from a doctor at a medical facility is the opportunities offered to attend intervention programs to eliminate the addict’s drug using and seeking behaviors and to have safe treatment. Distributing naloxone does not address the core problem which is the actual addiction.
|
|
#3 Argument AGAINST
|
Participants from other studies were reluctant to administer naloxone, because giving the medication to a patient requires constant medical surveillance and monitoring until they are fully revived or until a higher echelon of medical care arrives.
|
|
Concluding Sentence:
|
Distributing naloxone may be a good gesture, but the risks of increased drug use, accidental overdoses and masking the core problem of addiction outweigh the benefits.
|
CLOSING PARAGRAPH
|
A closing paragraph in which you state your opinion. |
Simply put, the benefits greatly do outweigh the risks here, and having been a former first responder to an overdose call before, and having administered two rounds of 0.4 mg of Naloxone intravenously before resuscitating a heavily sedated patient, I can say that the medication is definitely effective and I stand by its use, if used correctly and for the right purposes.
|
REFERENCES
|
AT LEAST 2 sources for your arguments FOR and AT LEAST 2 sources for your counterpoint arguments AGAINST from peer-reviewed journal articles, government reports or textbooks, using APA 6th edition. |
Bazazi, A. R., Zaller, N. D., Fu, J. J., & Rich, J.D. (2010). Preventing opiate overdose deaths: Examining objections to take-home naloxone. Journal of Health Care for the Poor and Underserved, 21(4), 1108-13. Retrieved from https://nuls.idm.oclc.org/login?url=http://search.proquest.com.nuls.idm.oclc.org/docview/ 816192333?accountid=25320
Breedvelt, J. J. F., Tracey, D. K., Dickenson, E. C., & Dean, L. V. (2015). "Take home" naloxone: What does the evidence base tell us? Drugs and Alcohol Today, 15 (2), 67-75. Retrieved from https://nuls.idm.oclc.org/login?url=http://search.proquest.com.nuls.idm.oclc.org/docview/ 1700641589?accountid=25320
Enteen, L., Bauer, J., Mclean, R., Wheeler, E., Huriaux, E., Kral, A. H., & Bamberger, J. D. (2010). Overdose prevention and naloxone prescription for opioid users in San Francisco. Journal of Urban Health, 87(6), 931-41. doi: http://dx.doi.org.nuls.idm.oclc.org/10.1007/s11524 - 010 - 9495 - 8
Faul, M., Dailey, M. W., Sugerman, D. E., Sasser, S. M., Levy, B., & Paulozzi, L. J. (2015). Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities. American Journal of Public Health, 105, E26E32. Retrieved from https://nuls.idm.oclc.org/login?url=http://search.proquest.com.nuls.idm.oclc.org/docview/ 1687987375?accountid=25320
Lankenau, S. E., Wagner, K. D., Silva, K., Kecojevic, A., Iverson, E., Mcneely, M., & Kral, A. H. (2013). Injection drug users trained by overdose prevention programs: Responses to witnessed overdoses. Journal of Community Health, 38(1), 133-41. doi: http://dx.doi.org.nuls.idm.oclc.org/10.1007/s10900 - 012 - 9591 - 7
Strang, J., Powis, B., Best, D., Vingoe, L., Griffiths P, Taylor C, Welch S, & Gossop M. (1999). Preventing opiate overdose fatalities with take-home naloxone: Pre-launch study of possible impact and acceptability. Addiction, 94(2), 199-204. Retrieved from https://nuls.idm.oclc.org/login?url=http://search.proquest.com.nuls.idm.oclc.org/docview/ 199558588?accountid=25320
|
COH 318 Point/Counterpoint Essay (Updated 7/24/17) Page 2